Apollo Endosurgery, Inc. (APEN): Price and Financial Metrics

Apollo Endosurgery, Inc. (APEN): $9.91

-0.01 (-0.10%)

POWR Rating

Component Grades














  • APEN scores best on the Sentiment dimension, with a Sentiment rank ahead of 66.01% of US stocks.
  • APEN's strongest trending metric is Value; it's been moving down over the last 155 days.
  • APEN ranks lowest in Momentum; there it ranks in the 13th percentile.

APEN Stock Summary

  • APEN's price/sales ratio is 5.75; that's higher than the P/S ratio of 81.88% of US stocks.
  • Over the past twelve months, APEN has reported earnings growth of 167.81%, putting it ahead of 91.25% of US stocks in our set.
  • The volatility of APOLLO ENDOSURGERY INC's share price is greater than that of 84.96% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to APEN, based on their financial statements, market capitalization, and price volatility, are BDSX, SGHT, EKSO, PHUN, and KTOS.
  • Visit APEN's SEC page to see the company's official filings. To visit the company's web site, go to www.apolloendo.com.

APEN Valuation Summary

  • In comparison to the median Healthcare stock, APEN's price/sales ratio is 205.26% higher, now standing at 5.8.
  • APEN's price/sales ratio has moved down 121.3 over the prior 194 months.

Below are key valuation metrics over time for APEN.

Stock Date P/S P/B P/E EV/EBIT
APEN 2023-03-24 5.8 9.8 -10.1 -12.3
APEN 2023-03-23 5.7 9.7 -10.1 -12.2
APEN 2023-03-22 5.7 9.7 -10.1 -12.2
APEN 2023-03-21 5.8 9.8 -10.2 -12.3
APEN 2023-03-20 5.8 9.8 -10.2 -12.3
APEN 2023-03-17 5.7 9.7 -10.1 -12.2

APEN Growth Metrics

    The 3 year price growth rate now stands at 32.46%.
  • Its 2 year price growth rate is now at 164.92%.
  • Its 3 year cash and equivalents growth rate is now at 166.97%.
APEN's revenue has moved down $7,767,392 over the prior 67 months.

The table below shows APEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 71.713 -25.298 -40.691
2022-06-30 68.491 -22.808 -35.902
2022-03-31 65.794 -18.834 -28.495
2021-12-31 62.989 -14.454 -24.682
2021-09-30 59.678 -12.91 -17.782
2021-06-30 56.153 -13.949 -13.722

APEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • APEN has a Quality Grade of D, ranking ahead of 22.64% of graded US stocks.
  • APEN's asset turnover comes in at 0.804 -- ranking 36th of 186 Medical Equipment stocks.
  • IDXG, BSGM, and ISR are the stocks whose asset turnover ratios are most correlated with APEN.

The table below shows APEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.804 0.554 -0.164
2021-06-30 0.733 0.549 -0.111
2021-03-31 0.619 0.534 -0.161
2020-12-31 0.590 0.529 -0.288
2020-09-30 0.584 0.507 -0.429
2020-06-30 0.555 0.488 -0.560

APEN Price Target

For more insight on analysts targets of APEN, see our APEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $14.00 Average Broker Recommendation 1.38 (Strong Buy)

APEN Stock Price Chart Interactive Chart >

Price chart for APEN

APEN Price/Volume Stats

Current price $9.91 52-week high $10.30
Prev. close $9.92 52-week low $3.49
Day low $9.91 Volume 510,756
Day high $9.93 Avg. volume 1,478,202
50-day MA $9.91 Dividend yield N/A
200-day MA $7.31 Market Cap 471.21M

Apollo Endosurgery, Inc. (APEN) Company Bio

Apollo Endosurgery, Inc. focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries. The company is based in Austin, Texas.

APEN Latest News Stream

Event/Time News Detail
Loading, please wait...

APEN Latest Social Stream

Loading social stream, please wait...

View Full APEN Social Stream

Latest APEN News From Around the Web

Below are the latest news stories about APOLLO ENDOSURGERY INC that investors may wish to consider to help them evaluate APEN as an investment opportunity.

Analysts Are Downgrading These 10 Stocks

In this article, we will discuss the 10 stocks recently downgraded by analysts. If you want to see more such stocks on the list, you can directly visit Analysts Are Downgrading These 5 Stocks. Microsoft Corporation (NASDAQ:MSFT) is in the news after the company posted fiscal Q2 results. The company’s revenue outlook for the March […]

Yahoo | January 26, 2023

Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity

Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT trial, published in The Lancet earlier this year(1), was selected as 2022 Top Story in Gastroenterology.(2) Additionally, the American Society for Metabolic and Bariatric Surgery (ASMBS) formally added four Apollo systems to its list of FDA Approved Bariatric Devices

Yahoo | December 13, 2022

Boston Scientific's (BSX) New Buyout to Expand its Portfolio

Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.

Yahoo | November 30, 2022

Bed Bath & Beyond (BBBY) Stock Rebounds After Black Friday Woes

Bed Bath & Beyond (BBBY) stock is bouncing back on Tuesday after the retail company's shares took a dive Monday on poor Black Friday sales.

William White on InvestorPlace | November 29, 2022

Why Is Otonomy (OTIC) Stock Up 97% Today?

Otonomy (OTIC) stock is on the move Tuesday with heavy trading despite a lack of news from the biopharmaceutical company.

William White on InvestorPlace | November 29, 2022

Read More 'APEN' Stories Here

APEN Price Returns

1-mo -0.40%
3-mo -0.30%
6-mo 86.98%
1-year 50.38%
3-year 384.76%
5-year 58.18%
YTD -0.60%
2022 18.27%
2021 147.94%
2020 19.30%
2019 -17.39%
2018 -38.39%

Continue Researching APEN

Want to see what other sources are saying about Apollo Endosurgery Inc's financials and stock price? Try the links below:

Apollo Endosurgery Inc (APEN) Stock Price | Nasdaq
Apollo Endosurgery Inc (APEN) Stock Quote, History and News - Yahoo Finance
Apollo Endosurgery Inc (APEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7531 seconds.